ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,055,705 | -39.4% | 85,690 | +12.7% | 0.14% | -25.4% |
| Q4 2021 | $5,040,000 | +9.2% | 76,020 | +2.8% | 0.18% | +4.5% |
| Q3 2021 | $4,617,000 | -28.3% | 73,960 | -4.8% | 0.18% | -18.1% |
| Q2 2021 | $6,435,000 | +44.5% | 77,700 | +15.7% | 0.22% | +35.0% |
| Q1 2021 | $4,454,000 | -11.4% | 67,165 | +2.6% | 0.16% | -14.9% |
| Q4 2020 | $5,025,000 | +46.4% | 65,490 | -17.9% | 0.19% | +39.3% |
| Q3 2020 | $3,433,000 | – | 79,730 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
| Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
| Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
| COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
| Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
| JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
| WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
| M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
| Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
| Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |